Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

Journal of Clinical Investigation

Volumn 103, Issue 2, 1999, Pages 185-195

  Igarashi, Masahiko ^a   Wakasaki, Hisao ^a   Takahara, Noriko ^a   Ishii, Hidehiro ^a   Jiang, Zhen Y ^a   Yamauchi, Teruaki ^a   Kuboki, Koji ^a   Meier, Matthias ^a   Rhodes, Christopher J ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; DIMETHYL SULFOXIDE; GLUCOSE; ISOENZYME; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; APOPTOSIS; ARTICLE; CATTLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPEROSMOLARITY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0032921465     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3326     Document Type: Article

References (68)

1. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329:977-986.
2. Greene, D., Lattimer, S.A., and Sima, A.A.F. 1987. Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:599-606.
3. Brownlee, M., Cerami, A., and Vlassara, H. 1988. Advanced glycosylation end products in tissue and biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321.
4. Williamson, J.R., et al. 1993. Hyperglycemic pseudhypoxia and diabetic complications. Diabetes. 42:801-813.
5. Koya, D., and King, G.L. 1998. Protein kinase C activation and the development of diabetic complication. Diabetes. 47:859-866.
6. Craven, P.A., and DeRubertis, F.R. 1989. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J. Clin. Invest. 83:1667-1675.
7. Craven, P.A., Davidson, C.M., and DeRubertis, F.R. 1990. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes. 39:667-674.
8. Ayo, S.H., Radnik, R., Garoni, J.A., Troyer, D.A., and Kreisburg, J.I. 1991. High glucose increases diacylglycerol mass and activate protein kinase C in mesangial cell culture. Am. J. Physiol. 261:F571-F577.
9. Inoguchi, T., et al. 1992. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA. 89:11059-11063.
10. Williams, B., and Schreier, R.W. 1992. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 41:1464-1472.
11. Shiba, T., et al. 1993. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. J. Physiol. 265:E783-E793.
12. Xia, P., et al. 1994. Characterization of mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactocemia. Diabetes. 43:1122-1129.
13. Kunisaki, M., et al. 1995. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am. J. Physiol. 269:E239-E246.
14. Kunisaki, M., Bursell, S.E., Umeda, F., Nawata, H., and King, G.L. 1995. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes. 43:1372-1377.
15. Ishii, H., et al. 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science. 272:728-731.
16. Koya, D., et al. 1997. Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest. 100:115-126.
17. Seger, R., and Krebs, E.G. 1995. The MAPK signaling cascade. FASEB J. 9:726-798.
18. Kundra, V., et al. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature. 367:474-476.
19. Bilato, C., et al. 1995. Intracellular signaling pathways are required for rat vascular smooth muscle cell migration. J. Clin. Invest. 96:1905-1915.
20. Haneda, M., et al. 1997. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 46:847-853.
21. Cano, E., Hazzalin, C.A., and Mahadevan, L.C. 1994. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol. 14:7352-7362.
22. Derijard, B., et al. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell. 76:1025-1037.
23. Han, J., Lee, J.D., Bibbs, L., and Ulevitch, R.J. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:808-811.
24. Chen, Y.R., Wang, X., Templeton, D., Davis, R.J., and Tan, T.H. 1996. The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:31929-31936.
25. Liu, Y., Gorospe, M., Yang, C., and Holbrook, N.J. 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270:8377-8380.
26. 2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J. Biol. Chem. 271:30950-30955.
27. Heine, H., Ulmer, A.J., Flad, H.-D., and Hauschildt, S. 1995. Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J. Immunol. 155:4899-4908.
28. Lee, J.C., et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:739-746.
29. Nick, J.A., Avdi, N.J., Gerwins, P., Johnson, G.L., and Worthen, G.S. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156:4867-4875.
30. Shapiro, L., and Dinarello, C.A. 1995. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. USA. 92:12230-12234.
31. Moriguchi, T., Kawasaki, H., Matsuda, S., Gotoh, Y., and Nishida, E. 1995. Evidence for multiple activators for stress-activated protein kinase/c-jun amino-terminal kinases. J. Biol. Chem. 270:12969-12972.
32. 2-kinase by UV irradiation is dependent on p21ras. J. Biol. Chem. 271:23304-23309.
33. Stein, B., Brady, H., Yang, M.X., Young, D.B., and Barbosa, M.S. 1996. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase cascade. J. Biol. Chem. 271:11427-11433.
34. Rouse, J., et al. 1994. A novel kinase cascade triggered by stress and heat shock that stimulate MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1027-1037.
35. Modur, V., Zimmerman, G.A., Prescott, S.M., and McIntyre, T.M. 1996. Endothelial cell inflammatory responses to tumor necrosis factor α. J. Biol. Chem. 271:13094-13102.
36. Raingeaud, J., et al. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420-7426.
37. Beyaert, R., et al. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J. 15:1914-1923.
38. Cuenda, A., Cohen, P., Buee-Scherrer, V., and Goedert, M. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:295-305.
39. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326-1330.
40. 2) in thrombin-stimulated platelets J. Biol. Chem. 271:27723-27729.
41. Nayak, R.C., Berman, A.B., George, K.L., Eisenbarrh, G.S., and King, G.L. 1988. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J. Exp. Med. 167:1003-1015.
42. 2. J. Clin. Invest. 96:733-740.
43. Yasuda, I., et al. 1990. A synthetic peptide substrate for selectivity assay of protein kinase C. Biochem. Biophys. Res. Commun. 166:1220-1227.
44. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1950. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
45. Reifel-Miller, A., et al. 1996. Protein kinase C isozymes differentially regulate promoters containing PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs. J. Biol. Chem. 271:21666-21671.
46. Morgenstern, J.P., and Land, H. 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
47. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
48. Bradford, M.M. 1976. A rapid and sensitive method of the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
49. Becker, T.C., BeltrandelRio, H., Noel, R.J., Johnson, J.H., and Newgard, C.B. 1994. Overexpression of hexokinase I in isolated islet of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J. Biol. Chem. 269:21234-21238.
50. Becker, T.C., et al. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43:161-389.
51. Denjard, B., et al. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:682-685.
52. Williams, B., and Schrier, R.W. 1993. Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J. Clin. Invest. 92:2889-2896.
53. Jirousek, M.R., et al. 1996. (S)-13-[Dimethylamino)methyl]-10, 11, 14, 15-tetrahydro-4.9:16, 21-dimetheno-1 H, 13H-dibenzo [e,k] pyrrolo [3, 4-h][1, 4, 13]oxadiazacyclohexadecene-1, 2 (2H)-dione (LY333351) and related analogues: isoform selective inhibitors of protein kinase C β. J. Med. Chem. 39:2664-2671.
54. Cuenda, A., et al. 1995. SB203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229-233.
55. Lin, A., et al. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 268:286-290.
56. Rosette, C., and Karin, M. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1194-1197.
57. MacFarlene, W.M., et al. 1997. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells. J. Biol. Chem. 272:20936-20944.
58. Krump, E., Sanghera, J.S., Pelech, S.L., Furuya, W., and Grinstein, S. 1997. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J. Biol. Chem. 272:937-944.
59. Haller, H., et al. 1995. High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int. 47:1057-1067.
60. Fukumoto, S., et al. 1997. Protein kinase C δ inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J. Biol. Chem. 272:13816-13822.
61. Lu, Z., et al. 1997. Tumor promotion by depleting cells of protein kinase C δ. Mol. Cell. Biol. 17:3418-3428.
62. Ueda, Y., et al. 1996. Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. 1996. J. Biol. Chem. 271:23512-23519.
63. Wang, X., and Ron, D. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1347-1349.
64. Ha, J., Jiang, Y., Li, Z., Kravchenko, V.V., and Ulevitch, R.J. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:296-299.
65. Vanden-Berghe, W., et al. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:3285-3290.
66. Saklatvala, J., et al. 1996. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J. Biol. Chem. 271:6586-6589.
67. 2 biosynthesis stimulated by interleukin-1β. J. Biol. Chem. 272:8083-8089.
68. Whitmarsh, AJ., Yang, S.H., Sharrocks, A.D., and Davis, R.J. 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:2360-2371.